Search Results for keywords:"contract proposals"

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 22, 2025, to discuss and evaluate contract proposals. This meeting will not be open to the public to protect confidential trade secrets, commercial information, and personal privacy. It will take place via video conference, and any inquiries can be directed to Anuja Mathew, Ph.D., at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on January 30-31, 2025. The purpose of the meeting is to review and evaluate contract proposals and it will be conducted via video conferencing from their office in Rockville, MD. The meeting is closed to protect confidential trade secrets and personal information, according to federal guidelines. For additional information, Vishakha Sharma, Ph.D., is the contact person.

The National Institute of Allergy and Infectious Diseases is holding two closed meetings to review and evaluate contract proposals. These meetings will focus on reagents for immunologic analysis of non-mammalian and underrepresented mammalian models as part of the Small Business Innovation Research (SBIR) program. The first meeting for Phase I will occur on January 28, 2021, from 10:00 a.m. to 6:00 p.m., and the second meeting for Phase II will take place on January 29, 2021, from 10:00 a.m. to 2:00 p.m. Both meetings will be held virtually and closed to the public to protect confidential trade secrets and personal privacy.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting to discuss and evaluate contract proposals as part of a collaborative effort with the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). This meeting is set to take place virtually on February 2, 2021, from 11:00 a.m. to 4:00 p.m. The discussions will include confidential trade secrets or commercial information and personal details, so it will be closed to the public. Dr. Lynn Rust is the contact person for more information about this meeting.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 3-4, 2024, to review contract proposals related to vaccine adjuvant development. This meeting is closed to the public to protect sensitive information like trade secrets and personal privacy. The meeting will take place via video at the NIH facility in Rockville, MD. For further details, Michael M. Opata, Ph.D., is the contact person.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting from April 14-16, 2025, to review and evaluate contract proposals related to the development of diagnostics for Mycoplasma genitalium infection. This meeting falls under specific federal regulations, which means it will not be open to the public to protect confidential and personal information. The discussions might involve trade secrets or sensitive commercial information. For more details, Dylan P. Flather, Ph.D., is the contact person available via email or phone.

The National Center for Advancing Translational Sciences has announced two upcoming closed meetings to review and evaluate contract proposals, scheduled on January 27 and January 29, 2025. These meetings will be held virtually and are closed to protect confidential trade secrets and personal information. The committees will focus on two main topics: developing a benchtop device for batch evaporation and creating liver and brain organoids from human iPS cells. Rahat (Rani) Khan, Ph.D., will be the contact person for these meetings.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting in accordance with the Federal Advisory Committee Act. The meeting, scheduled for February 4, 2025, will be held via video at the institute's Rockville, MD location. It will focus on reviewing and evaluating contract proposals related to CRISPR-based in vitro diagnostics for detecting certain pathogens. The meeting is closed to protect confidential trade secrets and personal information.

The National Heart, Lung, and Blood Institute announced that several meetings will be held in February 2025, but they will be closed to the public. These meetings are being organized to review grant applications and contract proposals, and they will be conducted virtually. The closed nature of the meetings is due to the potential disclosure of confidential information, such as trade secrets or personal data. Contact details for the Scientific Review Officers handling each meeting are provided for those seeking further information.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 21, 2025. The meeting, which will happen via video, aims to review and evaluate contract proposals related to CRISPR-based in vitro diagnostics for detecting specific pathogens. This session is closed to the public to protect confidential information and privacy. The meeting details and contact information are provided for scientific inquiries.